| 产品名称： | Staphylococcus aureus subsp. aureus Rosenbach |
|---|---|
| 商品货号： | TS209129 |
| Deposited As： | Staphylococcus aureus Rosenbach |
| Strain Designations： | Mu50 NRS1 |
| Application： | Drug discovery |
| Isolation： | Isolated from pus and debrided tissue at surgical incision in sternum of 4 month-old infant, Japan, 1996. |
| Biosafety Level： | 2 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Genotype： | pvl negative |
| Genome Sequenced Strain： | Staphylococcus aureus subsp. aureus Mu50 DNA, complete genome |
| Type Strain： | no |
| Antibiotic Resistance： | Methicillin resistant Oxacillin resistant Reduced vancomycin susceptibility |
| Comments： | Degree of resistance tends to decrease depending on the culture condition. Recommend propagating strain in Brain Heart Infusion with 4 mg/L vancomycin (ATCC Medium 2174). Genome sequenced strain MRSA SCCmec: Type II spa type Ridom: t002 spa type Kreiswirth: TJMBMDMGMK pvl gene amplification: Negative Phenotypic and genotypic information for ATCC MRSA strains, such as SCCmec, PFGE, or spa typing, is provided for informational purposes only. This information was compiled from testing performed by one or more sources, including ATCC, strain depositor, published data, or contracted research. Reduced vancomycin susceptibility |
| Medium： | ATCC® Medium 2174: Brain heart infusion medium with vancomycin 4 mcg/ml |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | K Hiramatsu |
| Special Collection： | NCRR Contract |
| References： | Hiramatsu K, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350: 1670-1673, 1997. PubMed: 9400512 Hiramatsu K, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40: 135-136, 1997. PubMed: 9249217 Keiichi Hiramatsu, personal communication Monecke S, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 6(4): e17936, 2011. PubMed: 21494333 |
| Cross References： | Nucleotide (GenBank) : BA000017 Staphylococcus aureus subsp. aureus Mu50 DNA, complete genome |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Staphylococcus aureus subsp. aureus Rosenbach |
|---|---|
| 商品货号： | TS209129 |
| Deposited As： | Staphylococcus aureus Rosenbach |
| Strain Designations： | Mu50 NRS1 |
| Application： | Drug discovery |
| Isolation： | Isolated from pus and debrided tissue at surgical incision in sternum of 4 month-old infant, Japan, 1996. |
| Biosafety Level： | 2 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Genotype： | pvl negative |
| Genome Sequenced Strain： | Staphylococcus aureus subsp. aureus Mu50 DNA, complete genome |
| Type Strain： | no |
| Antibiotic Resistance： | Methicillin resistant Oxacillin resistant Reduced vancomycin susceptibility |
| Comments： | Degree of resistance tends to decrease depending on the culture condition. Recommend propagating strain in Brain Heart Infusion with 4 mg/L vancomycin (ATCC Medium 2174). Genome sequenced strain MRSA SCCmec: Type II spa type Ridom: t002 spa type Kreiswirth: TJMBMDMGMK pvl gene amplification: Negative Phenotypic and genotypic information for ATCC MRSA strains, such as SCCmec, PFGE, or spa typing, is provided for informational purposes only. This information was compiled from testing performed by one or more sources, including ATCC, strain depositor, published data, or contracted research. Reduced vancomycin susceptibility |
| Medium： | ATCC® Medium 2174: Brain heart infusion medium with vancomycin 4 mcg/ml |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | K Hiramatsu |
| Special Collection： | NCRR Contract |
| References： | Hiramatsu K, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350: 1670-1673, 1997. PubMed: 9400512 Hiramatsu K, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40: 135-136, 1997. PubMed: 9249217 Keiichi Hiramatsu, personal communication Monecke S, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 6(4): e17936, 2011. PubMed: 21494333 |
| Cross References： | Nucleotide (GenBank) : BA000017 Staphylococcus aureus subsp. aureus Mu50 DNA, complete genome |
